Phase II open label trial of imatinib in polycythemia rubra vera
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology
Link
http://link.springer.com/content/pdf/10.1007/s12185-008-0193-1.pdf
Reference25 articles.
1. Dai CH, Krantz SB, Green WF, et al. Polycythemia vera. III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression. Br J Haematol. 1994;86:12–21. doi: 10.1111/j.1365-2141.1994.tb03246.x .
2. Dai CH, Krantz SB, Koury ST, et al. Polycythemia vera. IV. Specific binding of stem cell factor to normal and polycythemia vera highly purified erythroid progenitor cells. Br J Haematol. 1994;88:497–505. doi: 10.1111/j.1365-2141.1994.tb05065.x .
3. Dai CH, Krantz SB, Sawyer ST. Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells; a possible defect of phosphatase activity in polycythemia vera. Blood. 1997;89:3574–81.
4. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2–V617F2 mutation leading to constitutive signaling causes polycythemia vera. Nature. 2005;434:1144–8. doi: 10.1038/nature03546 .
5. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Cancer Genome Project. Acquired mutation of the tyrosine kinase JAK2–V617F2 in human myeloproliferative disorders. Lancet. 2005;365:1054–61.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of imatinib mesylate in patients with polycythemia vera: results of a phase II study;Annals of Hematology;2013-03-24
2. Case of polycythemia vera concurrent with FIP1L1-PDGFRA–positive myeloproliferative neoplasm with eosinophilia;Cancer Genetics;2012-10
3. Long term follow-up of Polycythemia Vera patients treated with imatinib mesylate;Leukemia Research;2012-07
4. Treatment of polycythemia vera with imatinib mesylate;Leukemia Research;2012-02
5. Cutaneous Lymphoid Hyperplasia, Cutaneous T-cell Lymphoma, Other Malignant Lymphomas, and Allied Diseases;Andrews' Diseases of the Skin;2011
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3